---
schema_version: "secwatch.filing_event.v1"
accession: "0001022079-22-000048"
form_type: "8-K"
ticker: "DGX"
cik: "0001022079"
company_name: "QUEST DIAGNOSTICS INC"
filed_at: "2022-03-02T23:59:59+00:00"
generated_at: "2026-06-27T02:15:28.918927+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Quest Diagnostics director Dr. Helen I. Torley will not seek re-election; board size reduced to 9

## Summary
- Dr. Torley, President & CEO of Halozyme, chose not to stand for re-election at the May 18, 2022 annual meeting.
- Board reduced its size from 10 to 9 directors, effective at the annual meeting.
- Dr. Torley cited a desire to focus on board service for companies developing innovative medicines.
- No disagreement with the company was disclosed regarding her departure.

## SEC filing metadata
- accession: 0001022079-22-000048
- form_type: 8-K
- ticker: DGX
- cik: 0001022079
- company_name: QUEST DIAGNOSTICS INC
- filed_at: 2022-03-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1022079/000102207922000048/0001022079-22-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1022079/000102207922000048/dgx-20220224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001022079-22-000048
- JSON: https://secwatch.observer/filing/0001022079-22-000048.json
- Plain text: https://secwatch.observer/filing/0001022079-22-000048.txt

## Key facts
- Executive change
  Helen I. Torley departed as Director at QUEST DIAGNOSTICS INC.
  - Action: not seek re-election
  - Role: Director
  source text: On February 24, 2022, Dr. Helen I. Torley informed the Company of her decision to not seek re-election to the Company’s Board of Directors (the “Board”) at the Company’s Annual Meeting of Stockholders to be held May 18, 2022 (the “Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1022079/000102207922000048/0001022079-22-000048-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.